Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: Loss of chromosome 1q21.3 is associated with shorter overall survival

Cancer

Volumn 115, Issue 7, 2009, Pages 1576-1585

  Maru, Dipen M ^a,b   Luthra, Rajyalakshmi ^a   Correa, Arlene M ^a   White Cross, Jill ^a   Anandasabapathy, Sharmila ^a   Krishnan, Sunil ^a   Guha, Sushovan ^a   Komaki, Ritsuko ^a   Swisher, Stephen G ^a   Ajani, Jaffer A ^a   Hofstetter, Wayne L ^a   Rashid, Asif ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adenocarcinoma; Chromosome 1q; Esophagus; Loss of heterozygosity

Indexed keywords

FLUOROURACIL; TAXANE DERIVATIVE; TUMOR MARKER;

ADULT; AGED; ALLELE; ARTICLE; BARRETT ESOPHAGUS; CHROMOSOME 1Q; CLINICAL ARTICLE; DNA MICROARRAY; EPIGENETICS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; FEMALE; GENE LOCATION; GENE LOCUS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; MALE; MICROSATELLITE MARKER; PRIORITY JOURNAL;

ADENOCARCINOMA; CHROMOSOMES, HUMAN, PAIR 1; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED;

EID: 63449140431     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24122     Document Type: Article

References (25)

1. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142-146.
2. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemo- radiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305-313.
3. Walsh TN, Noonan N, Hollywood D. A comparison of multimodal therapy and surgery for esophageal adenocarci- noma. N Engl J Med. 1996;335:462-467.
4. Kleinberg L, Forastiere AA. Chemoradiation in the management of esophageal cancer. J Clin Oncol. 2007;25:4110-4117.
5. Rizk NP, Venkatraman E, Bains MS, et al. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol. 2007;25:507-512.
6. Darnton SJ, Archer VR, Stocken DD, Mulholland PJ, Casson AG, Ferry DR. Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival. J Clin Oncol. 2003;21:4009-4015.
7. Gaca JG, Petersen RP, Peterson BL, et al. Pathologic nodal status predicts disease-free survival after neoadjuvant che- moradiation for gastroesophageal junction carcinoma. Ann Surg Oncol. 2006;13:340-346.
8. Luthra R, Wu TT, Luthra MG, et al. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol. 2006;24:259-267.
9. Kimchi ET, Posner MC, Park JO, et al. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res. 2005;65:3146-3154.
10. Siewert JR, Stein HJ. Classification of adenocarcinoma of the esophagogastric junction. Br J Surg. 1998;85:1457-1459.
11. Greene FL, Page DL, Fleming ID, et al, eds. American Joint Committee on Cancer staging manual. 6th ed. New York: Springer; 2002:77-89.
12. Chirieac LR, Swisher SG, Ajani JA, et al. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer. 2005;103:1347-1355.
13. Moskaluk CA, Kern SE. Microdissection and polymerase chain reaction amplification of genomic DNA from histo- logical tissue sections. Am J Pathol. 1997;150:1547-1552.
14. Li J, Liu Z, Wang Y, et al. Allelic imbalance of chromosome 1q in esophageal squamous cell carcinomas from China: a novel region of allelic loss and significant association with differentiation. Cancer Lett. 2005;220:221-230.
15. Inagaki Y, Yasui K, Endo M, et al. CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma. Cancer Genet Cytoge- net. 2008;180:30-36.
16. Sy SM, Wong N, Lai PB, To KF, Johnson PJ. Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma. Mod Pathol. 2005;18:686-692.
17. Koon N, Zaika A, Moskaluk CA, et al. Clustering of molecular alterations in gastroesophageal carcinomas. Neoplasia. 2004;6:143-149.
18. Gaki V, Tsopanomichalou M, Sourvinos G, Tsiftsis D, Spandidos DA. Allelic loss in chromosomal region 1q21-23 in breast cancer is associated with peritumoral angiolym- phatic invasion and extensive intraductal component. Eur J Surg Oncol. 2000;26:455-460.
19. Chen YJ, Vortmeyer A, Zhuang Z, Huang S, Jensen RT. Loss of heterozygosity of chromosome 1q in gastronomes: occurrence and prognostic significance. Cancer Res. 2003;63:817-823.
20. Sy SM, Wong N, Lee TW, et al. Distinct patterns of genetic alterations I adenocarcinoma and squamous cell carcinoma of the lung. Eur J Cancer. 2004;40:1082-1094.
21. Luthra MG, Ajani JA, Izzo J, et al. Decreased expression of gene cluster at chromosome 1q21 defines molecular subgroups of chemoradiotherapy response in esophageal cancers. Clin Cancer Res. 2007;13:912-919.
22. Hammoud ZT, Kesler KA, Ferguson MK, et al. Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Dis Esophagus. 2006;19:69-72.
23. Schneider PM. Baldus SE, Metzger R, et al. Histomorpho-logic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg. 2005;242:684-692.
24. Chirieac LR, Swisher SG, Correa AM, et al. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma. Clin Cancer Res. 2005;11:2229-2236.
25. Heizmann CW, Ackermann GE, Galichet A. Pathologies involving the S100 proteins and RAGE. Subcell Biochem. 2007;45:93-138.